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Introduction
Bloodstream infections (BSIs) remain a crucial pub-
lic health problem of increasing incidence and impor-
tance in the modern world, whereas, they are charac-
terized by high morbidity and mortality (Wisplinghoff 
et al., 2004; Bouza et al., 2014; Koupetori et al., 2014). 
The reported raising incidence can be explained by the 
ageing of hospitalized patients, the increasing number 
of immunosuppressed patients and the acquisition of 
virulence factors by common pathogens (Goto and 
Al-Hasan, 2013; Papadimitriou-Olivgeri et al., 2015). 
The wide use of invasive devices, such as central venous 
catheters, is another important factor leading to the rise 
of the number of catheter-related bloodstream infec-
tions (CR-BSIs) (Rodriguez-Creixems et al., 2013).
Resistance to antimicrobial agents played a deter-
mining role in the epidemiology of bloodstream infec-
tions during the last decades (Koupetori et al., 2014). 
While Gram-negatives were the most common cause of 
BSIs before 90s (Karchmer, 2000), this changed after the 
dissemination of resistant Gram-positive bacteria, such 
as methicillin-resistant Staphylococcus aureus and van-
comycin resistant enterococci (VRE) (de Kraker et al., 
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A b s t r a c t
The aim of the study was to assess the epidemiology, the incidence of multidrug-resistant bacteria and bloodstream infections’ (BSIs) 
seasonality in a university hospital. This retrospective study was carried out in the University General Hospital of Patras, Greece, during 
2011–13 y. Blood cultures from patients with clinical presentation suggestive of bloodstream infection were performed by the BacT/ALERT 
System. Isolates were identified by Vitek 2 Advanced Expert System. Antibiotic susceptibility testing was performed by the disk diffusion 
method and E-test. Resistance genes (mecA in staphylococci; vanA/vanB/vanC in enterococci; blaKPC/blaVIM/blaNDM in Klebsiella spp.) 
were detected by PCR. In total, 4607 (9.7%) blood cultures were positive from 47451 sets sent to Department of Microbiology, represent-
ing 1732 BSIs. Gram-negative bacteria (52.3%) were the most commonly isolated, followed by Gram-positive (39.5%), fungi (6.6%) and 
anaerobes bacteria (1.8%). The highest contamination rate was observed among Gram-positive bacteria (42.3%). Among 330 CNS and 150 
Staphylococcus aureus, 281 (85.2%) and 60 (40.0%) were mecA-positive, respectively. From 113 enterococci, eight were vanA, two vanB and 
two vanC-positives. Of the total 207 carbapenem-resistant Klebsiella pneumoniae (73.4%), 202 carried blaKPC, four blaKPC and blaVIM and one 
blaVIM. A significant increase in monthly BSIs’ incidence was shown (R2: 0.449), which may be attributed to a rise of Gram-positive BSIs 
(R2: 0.337). Gram-positive BSIs were less frequent in spring (P < 0.001), summer (P < 0.001), and autumn (P < 0.001), as compared to winter 
months, while Gram-negative bacteria (P < 0.001) and fungi (P < 0.001) were more frequent in summer months. BSIs due to methicillin 
resistant S. aureus and carbapenem-resistant Gram-negative bacteria increased during the study period. The increasing incidence of BSIs 
can be attributed to an increase of Gram-positive BSI incidence, even though Gram-negative bacteria remained the predominant ones. 
Seasonality may play a role in the predominance of Gram-negative’s BSI.
K e y  w o r d s: bacteremia, Candida non-albicans, Staphylococcus aureus, carbapenem-resistance, methicillin resistant vancomycin 
 resistant enterococci (VRE)
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2013). Thus, the last two decades Gram-positive bacte-
ria were the most prominent worldwide (Wisplinghoff 
et al., 2004; de Kraker et al., 2013; Gubbels et al., 2015). 
The dissemination of carbapenem-resistant bacteria 
has changed the situation and currently Gram-negative 
ones have become the most common cause of BSIs in 
countries where these bacteria have invaded (Koupetori 
et al., 2014). Besides the role of resistance, studies have 
shown that environmental factors, such as, higher tem-
peratures, can influence the epidemiology (Eber et al., 
2011; Paul, 2012). It has been reported that Escherichia 
coli is more prominent in higher temperatures (Eber 
et al., 2011; Paul, 2012). In a multicenter study, it was 
shown that countries with low distance from the equator 
have higher proportion of Gram-negative bacteremias as 
compared to Gram-positive ones (Fisman et al., 2014).
The aim of the present study was to assess the evo-
lution of bloodstream infections, especially, those 
related with the use of intravenous catheters, to deter-
mine the causative agents and spread of multidrug 
resi s tant (MDR) isolates, as well as, to evaluate the 
role of seasonality in trends of microorganisms isola-
tion during a three-year period in a tertiary university 
Greek hospital.
Experimental
Materials and Methods
This retrospective observational study has taken 
place in the University General Hospital of Patras 
(UGHP), Greece, a 770 bed tertiary hospital. The 
UGHP is the only tertiary hospital in Southwestern 
Greece, receiving patients from eight prefectures with 
921 852 total population served. The study was carried 
out under the Hospital Surveillance Programme for 
multi-drug resistant infections of hospitalized patients, 
and was approved by the University Hospital Ethics 
Committee (HEC No: 571). 
During a three-year period (from January 2011 
till December 2013), two blood sets (consisted of an 
aerobic and an anaerobic blood culture bottle) from 
peripheral sites and one from the central venous line 
(if present) were obtained and sent to the Department 
of Microbiology, whenever a patient developed fever 
(≥ 38.0°C) or the clinical presentation was suggestive 
of bloodstream infection. The BacT/ALERT System 
(bioMerieux, Marcy l’Etoile, France) for blood culture 
incubation is used in our setting. Prolonged incubation 
(until 28 days) of blood culture bottles was applied in 
cases of suspicion for Brucella spp. or HACEK infection 
(Haemophilus spp., Aggregatibacter actinomycetemcomi-
tans, Cardiobacterium hominis, Eikenella corrodens and 
Kingella spp.). Catheter tips from central venous lines of 
septic patients were processed and cultured by the roll-
ing plate method onto blood agar plates (bioMerieux). 
Isolates recovered from positive blood cultures and 
catheter tips were identified by Gram stain, catalase 
and coagulase production and by the Vitek 2 Advanced 
Expert System (bioMerieux). Antibiotic susceptibility 
testing was performed by the agar disk diffusion method 
against antimicrobials suggested by EUCAST according 
to bacterial species, whereas the E-test was applied as 
follows: for Enterobacteriacae and Acinetobacter spp. 
imipenem, meropenem, colistin and tigecycline were 
tested; for Pseudomonas spp. imipenem, meropenem 
and imipenem/EDTA; for staphylococci, enterococci 
and streptococci vancomycin, teicoplanin, linezolid and 
daptomycin; for Streptococcus pneumoniae penicillin, 
ampicillin, cefepime, cefotaxime and ceftriaxone; for 
anaerobic bacteria penicillin, ampicillin, amoxicillin-
clavulanic acid, piperacillin, piperacillin-tazobactam, 
ticarcillin, imipenem, meropenem and clindamycin, 
whereas Gram-positive anaerobic bacteria were addi-
tionally tested for vancomycin (EUCAST, 2015). All 
results were interpreted according to EUCAST guide-
lines (EUCAST, 2015). 
BSI was defined according to CDC definition 
(Horan et al., 2008). Isolation of a common commensal 
organism from blood cultures, such as Aerococcus spp., 
Bacillus spp., coagulase-negative staphylococci (CNS), 
Corynebacterium spp., Micrococcus spp., Propionibacte-
rium spp., and viridans group streptococci, was char-
acterized as true BSI if the pathogen was isolated from 
at least two blood culture sets, as described by CDC 
guidelines (Horan et al., 2008). For all other pathogens, 
only one positive blood culture associated with clinical 
signs of infection were needed in order to be defined 
as BSI. CR-BSI was defined when the central venous 
catheter tip grew over 15 colony-forming units of the 
phenotypically same strain as the blood culture isolate. 
Positive blood cultures that were not associated with 
BSI were characterized as contamination. 
Phenotypic identification of carbapenemase pro-
duction among imipenem-resistant Enterobacteriaceae 
was performed by the EDTA synergy test (MER/MER-
EDTA) and the boronic acid synergy test (MER/MER-
boronic acid) by the disk diffusion method, which 
distinguishes the production of MBL and serine car-
bapenemase (Tsakris et al., 2010). All imipenem-non-
susceptible (IMP-NS) Pseudomonas aeruginosa isolates 
(MICs ≤ 1 mg/l) were examined for metallo-beta-lac-
tamase (MBL) production using the E-test MBL assay 
(bioMerieux).
PCR was used to identify mecA gene in pheno-
typically cefoxitin-resistant staphylococci, vanA, vanB 
and vanC genes in phenotypically vancomycin-resistant 
enterococci and blaKPC, blaVIM and blaNDM in pheno-
ty pically carbapenem-resistant Klebsiella pneumo- 
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niae isolates (Queenan and Bush, 2007; Papadimitriou-
Olivgeris et al., 2015).
SPSS version 19.0 (SPSS, Chicago, IL) software was 
used for all analyses. Bacterial BSI trends that were 
assessed by Spearman’s correlation analysis. Incidence 
was defined as the number of BSI of a pathogen per 
10 000 patient-days for all pathogens, while for Brucella 
spp. BSI yearly incidence was defined per 100 000 habit-
ants of western Greece. Poisson regression distribution 
with general log-linear analysis was used to estimate the 
adjusted incidence rate ratios (aIRR) with 95% confi-
dence intervals (CI) by comparing the BSI incidence 
according to the season of occurrence. P < 0.05 was 
considered statistically significant.
Results
During the study period, in total 47457 blood cul-
tures sets were processed in the Microbiology Depart-
ment, corresponding to 15292, 16335 and 15824 the 
years 2011, 2012 and 2013, respectively. Among them, 
1464 (9.6%), 1619 (9.9%) and 1524 (9.6%) were posi-
tive collected from 903, 1010 and 1024 patients, accord-
ingly. Gram-positive bacteria represented the majority 
of isolates (2653, 57.6%), followed by Gram-negative 
ones (1693, 36.7%), fungi (197, 4.3%) and anaerobes 
(64, 1.4%) (Table I). More specifically, CNS (n = 1808), 
especially Staphylococcus epidermidis (n = 1115) was the 
most common species among Gram-positive bacteria 
followed by S. aureus (n = 309), enterococci (n = 167), 
streptococci (n = 204), and others Gram-positive 
(n = 142). Klebsiella spp. was isolated from 632 blood 
cultures, while E. coli, P. aeruginosa, Acinetobacter spp., 
other Enterobacteriaceae, Brucella melitensis and other 
Gram-negative bacteria were isolated from 632, 320, 
232, 231, 151, 59 and 68, respectively. 
During the study period, 2115 catheter tips were 
evaluated (761 in 2011, 686 in 2012 and 668 in 2013). 
Among them, 267 (35.1%), 272 (39.7%) and 240 (35.9%) 
were culture-positive, recovered from 230, 253 and 
224 patients, respectively. The isolated pathogens in 
declining order were: CNS (358), Klebsiella spp. (145), 
Acinetobacter spp. (110), fungi (43), P. aeruginosa (37), 
S. aureus (23), enterococci (17), Enterobacteriaceae 
other than Klebsiella spp. and E. coli (16), streptococci 
(eight), E. coli (eight), other Gram-positive (seven), 
other Gram-negative (seven). 
Aforementioned positive blood cultures represented 
1732 BSIs (486, 606 and 640 in 2011, 2012 and 2013, 
respectively), of which 312 (18.0%) where catheter-
related. Gram-negative bacteria were the main cause 
of BSI (901, 52.3%), followed by Gram-positive (685, 
39.5%), fungi (115, 6.6%) and anaerobes (31, 1.8%).
The number of positive blood cultures associated 
with true BSI or contamination is shown in Table  I. 
The highest contamination rate was observed for 
Gram-positive bacteria (42.3%). No blood culture 
positive for Gram-negative bacteria or fungi was con-
sidered as contamination. Table II and Fig. 1 depict the 
rates of isolates from BSIs according to pathogen iso-
lated and the Department of patients’ hospitalization. 
Fig. 1. Bloodstream infection rates according to pathogen isolated and the Department of patient’s hospitalization. ICU, Intensive Care 
Unit; CNS, coagulase negative staphylococci.
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In the Paediatric Departments, including the neonatal 
ICU, Gram-positive bacteria predominate, whereas, 
in all adult Departments Gram-negatives prevailed 
(Table II, Fig. 1).
Figure 2 shows the monthly variation of BSIs’ inci-
dence per 10000 patient-days during the study period. 
A  significant rise was observed (R2: 0.449; P  0.006) 
that may be attributed to the rise in Gram-positive 
BSIs (R2: 0.337; P 0.044). No significant variation was 
observed for Gram-negatives, anaerobes or fungi. No 
pathogen had a significant variation in BSI’s incidence 
during the study period, with the exception of BSIs 
caused by S. aureus which increased from 2.0 per 10 000 
patient-days in 2011 to 3.4 in 2013 (R2: 0.995; P 0.033). 
When B. melitensis’ BSI yearly incidence was calculated 
according to the population of Southwestern Greece 
a significant rise was found, from 0.4 per 100 000 habit-
ants in 2011 to 1.5 in 2013 (R2: 0.974; P < 0.001). 
Figure 3 depicts the seasonal adjusted incidence rate 
ratio of BSIs according to isolated pathogen category 
(Gram-positive, Gram-negative, anaerobes, fungi), as 
compared to winter. The incidence of BSIs was 19% 
higher in summer months (P  0.024; aIRR 1.19; 95% 
CI 1.02–1.39) and 25% less frequent in autumn (P 0.001; 
aIRR 0.75; 95% CI 0.63–0.89) as compared to winter. 
BSIs due to Gram-positive bacteria was less frequent 
in spring (P < 0.001; aIRR 0.052; 95% CI  0.40–0.68), 
summer (P < 0.001; aIRR 0.58; 95% CI  10.45–0.74) 
and autumn (P < 0.001; aIRR 0.61; 95% CI 0.47–0.77), 
while Gram-negative bacteria (P < 0.001; aIRR 1.84; 
95% CI  1.47–2.29) and fungi (P < 0.001; aIRR 3.20; 
95%  CI  1.57–6.51) were more frequent in summer 
months. No significant difference was observed in BSIs’ 
incidence due to anaerobes.
Among the 330 CNS and the 150 S. aureus BSIs, 
281 (85.2%) and 60 (40.0%) were methicillin-resistant 
Gram-positive 2653 (57.6%) 1121 (98.3%) 42.3% 1532 (44.2%) 2.2 685 (39.5%)
CNS 1808 (39.2%)  944 (82.8%) 52.2%  864 (2.5%) 2.6 330 (19.1%)
S. epidermidis 1115 (24.2%)  436 (38.2%) 39.1%  679 (19.6%) 2.6 265 (14.7%)
Non-S. epidermidis  693 (15.0%)  508 (44.6%) 73.3%  185 (5.3%) 2.8  65 (3.8%)
S. aureus  309 (6.7%)    0 (0.0%) 0.0%  309 (8.9%) 2.0 151 (8.7%)
Enterococci  167 (3.6%)    0 (0.0%) 0.0%  167 (4.8%) 1.5 113 (6.5%)
Streptococci  204 (4.4%)   52 (4.6%) 25.5%  152 (4.4%) 2.1  73 (4.2%)
Other   142a (3.1%)  102 (8.9%) 71.8%   40 (1.2%) 2.2  18b (1.0%)
Gram-negative 1693 (36.7%)    0 (0.0%) 0.0% 1693 (48.8%) 1.9 901 (52.3%)
Klebsiella spp.  632 (13.7%)    0 (0.0%) 0.0%  632 (18.2%) 2.2 282 (16.3%)
E. coli  320 (6.9%)    0 (0.0%) 0.0%  320 (9.2%) 1.7 189 (10.9%)
Acinetobacter spp.  231 (5.0%)    0 (0.0%) 0.0%  231 (6.7%) 1.5 151 (8.7%)
P. aeruginosa  232 (5.0%)    0 (0.0%) 0.0%  232 (6.7%) 1.9 120 (6.9%)
Enterobacteriaceae  151 (3.3%)    0 (0.0%) 0.0%  151 (4.4%) 1.7  90 (5.2%)
B. melitensis   59 (1.3%)    0 (0.0%) 0.0%   59 (1.7%) 2.4  25 (1.4%)
Other   68c (1.5%)    0 (0.0%) 0.0%   68 (2.0%) 1.5  44d (2.5%)
Anaerobes   64e (1.4%)   19 (1.7%) 29.7%   45 (1.3%) 1.5  31f (1.8%)
Fungi  197g (4.3%)    0 (0.0%) 0.0%  197 (5.7%) 1.7 115h (6.6%)
Table I
Number of positive blood cultures associated with true bloodstream infections or contamination
CNS, coagulase negative staphylococci; BSI, bloodstream infections
a Corynebacterium spp. (72), Micrococcus spp. (30), Bacillus spp. (27), Listeria monocytogenes (eight), Aerococcus spp. (three), Leuconostoc spp. (two)
b Listeria monocytogenes (seven), Corynebacterium spp. (five), Aerococcus spp. (two), Bacillus spp. (two), Micrococcus spp. (two)
c Strenotrophomonas maltophilia (20), Sphingomonas spp. (eight), Burkholderhia cepacia (four), Morganella morgannii (four), Alcaligenes spp. (three), 
Achromobacter putrefasciens (two), Moraxella spp. (two), Neisseria meningitidis (one), Rhizobium radiobacter (one), Haemophilus influenzae (one)
d Strenotrophomonas maltophilia (14), Sphingomonas spp. (13), Morganella morgannii (four), Alcaligenes spp. (three), Burkholderhia cepacia (three), 
Achromobacter putrefasciens (two), Moraxella spp (two), Neisseria meningitidis (one), Rhizobium radiobacter (one), Haemophilus influenzae (one)
e Propionibacterium spp. (25), Bacteroides spp. (22), Peptococcus spp. (seven), Clostridium spp. (three), Peptostreptococcus spp. (three), Eubacte-
rium spp. (two), Fusobacterium spp. (two)
f Bacteroides spp. (14), Peptococcus spp. (five), Clostridium spp. (three), Propionibacterium spp. (three), Eubacterium spp. (two), Fusobacterium spp. 
(two), Peptostreptococcus spp. (two)
g Candida parapsilosis (94), C. albicans (70), C. glabrata (22), C. tropicalis (eight), Cryptococcus neoformans (two), C. kruzei (one)
h C. parapsilosis (50), C. albicans (44), C. glabrata (15), C. tropicalis (three), Cryptococcus neoformans (two), C. kruzei (one)
Isolates
Positive blood cultures
All (4607) Associated withcontamination (1140)
Contamination
rate (24.7%)
Associated with
BSI (3467)
Number per BSI
episode (2.0)
BSI episodes 
(1732)
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(mecA-positive; MR-CNS and MRSA), respectively. 
Among the 113 enterococci, 12  (10.6%) were VRE 
(eight vanA, two vanB and two vanC-positive). Car-
bapenem-resistance was observed in 207 K. pneumo-
niae (73.4%); 202 blaKPC, four blaKPC and blaVIM, one 
were blaVIM-positive, whereas, none carried blaNDM. 
Moreover, 96 (63.6%) Acinetobacter spp., 43 (35.8%) 
P. aeruginosa and 12 (13.3%) Enterobacteriaceae were 
MBL-positive. No E. coli was carbapenem-resistant. An 
increase in MRSA BSIs incidence was observed during 
the study period (0.9 per 10000 patient-days in 2011 to 
1.3 in 2013; R2: 0.987; P 0.014), while no significant var-
iation was observed in MR-CNS and VRE incidence. In 
total, BSIs due to carbapenem-resistant Gram-negative 
bacteria increased from 5.3 to 7.4 per 10000 patient-
days; R2: 0.818; P 0.042).
Among the 115 patients with fungemia, 113 epi-
sodes (98.2%) were caused by Candida spp. (50 Candida 
parapsilosis, 44 Candida albicans, 15 Candida glabrata, 
three Candida tropicalis, one Candida kruzei). Among 
patients with candidemia, 38 (33.6%) had a pre vious 
episode of bacteremia (21 due to KPC-producing 
Fig. 3. Seasonal adjusted incidence of BSIs rate ratio according to isolated pathogen Winter months were defined as reference.
* P < 0.05; ** P < 0.001
Fig. 2. Monthly variation of bloodstream infection incidence per 10000 patient-days during the study period
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K. pneumoniae, six Staphylococcus spp. four Acinetobac-
ter spp., three enterococci, two P. aeruginosa and two 
E. coli). Previous KPC-producing K. pneumoniae BSI 
was significantly higher among Candida non-albicans 
BSIs as compared to those caused by C. albicans (19 of 
69, 27.5% vs two of 44, 4.5%; P 0.002).
Discussion
BSIs comprise one of the commonest types of 
infections in hospitalized patients, associated with 
high mortality (12.0–43.0%) (Goto and Al-Hasan, 
2013; Bouza et al., 2014). The incidence of BSIs (com-
munity and healthcare-associated) in our study was 
13.6 per 1000 admissions. A point prevalence study 
of healthcare-associated infections in European hos-
pitals in 2011–12 found that 1.7% of patients from 
Greek hospitals developed a BSI, percentage com-
parable to ours (1.4%) (ECDC, 2013). BSIs rate in 
Greece was the highest (18.9%) among the European 
countries (10.7%) (ECDC, 2013). The incidence of BSIs 
was higher in our study as compared to those reported 
in a review from healthcare-associated BSIs from Euro-
pean countries and USA (2.7–8.4 per 1000 admissions), 
but was significantly lower to that reported from ‘Lai-
kon’ General Hospital, a tertiary hospital in Athens, 
Greece, from 1995 to 2002 (26.9 per 1000 admissions) 
(Hadziyannis et al., 2004; Goto and Al-Hasan, 2013). 
Overall, Southern European countries, including 
Greece, show higher prevalence of healthcare associated 
infections as compared to those of Central or North 
Europe (ECDC, 2013). A significant rise in BSIs inci-
dence was observed during the study period, a finding 
similar to that in other studies, probably due to ageing 
of hospitalized population, growing number of immu-
nocompromised patients and increased use of invasive 
devices (Hadziyannis et al., 2004; de Kraker et al., 2013; 
Bouza et al., 2014).
The pathogens responsible for BSIs vary widely 
between continents and countries. (Wisplinghoff 
et al., 2004; ECDC, 2013; Anderson et al., 2014). In our 
study, Gram-negative bacteria were the predominant 
pathogens (52.3%), followed by Gram-positive (39.5%), 
fungi (6.6%) and anaerobes (1.8%). Even though, our 
results are close to those reported in related studies 
from Greece and Spain (Bouza et al., 2014; Koupetori 
et al., 2014), these findings differ from those of other 
European countries and North America reporting 
that during the last two decades Gram-positive bac-
teria have become the most common cause of sepsis 
(Hadziyannis et al., 2004; de Kraker et al., 2013; ECDC, 
2013; Anderson et al., 2014; Gubbels et al., 2015). On 
the other hand, countries with closer proximity to 
equator exhibit higher percentages of Gram-negative 
BSIs (Fisman et al. 2014). Despite the predominance 
of Gram negatives in our and other Greek studies, 
a significant increase of Gram-positive incidence was 
detected in our setting, mainly attributed mainly to an 
increase of S. aureus BSIs. The same rising trend in BSIs 
due to Gram-positive bacteria was reported in a study 
from 31 Greek hospitals due to an increase in CNS and 
S. aureus incidence (Koupetori et al., 2014). Taking into 
account results from aforementioned study and the pre-
sent one, we may hypothesize that in the future we will 
witness in Greece a shift in BSIs etiology from Gram-
negative towards Gram-positive bacteria.
In most studies, E. coli, S. aureus, enterococci and 
streptococci constitute the most commonly isolated 
pathogens from BSIs, findings that contradict our 
results, where CNS and Klebsiella spp. were the main 
pathogens, followed by E. coli, Acinetobacter spp. and 
S. aureus (de Kraker et al., 2013; ECDC, 2013; Ander-
son et al., 2014; Gubbels et al., 2015; Khatib et al., 2015). 
A great disparity of isolated pathogens rates among the 
different Departments of our Hospital was found. In the 
Emergency Department, E. coli, S. aureus and strepto-
cocci were the most common cause of BSIs, reflecting 
the epidemiology of community-associated bacteremic 
infections (E. coli from urinary tract and abdominal 
infections, streptococci from respiratory tract infec-
tions, and S. aureus from skin and soft tissue infections) 
(ECDC, 2013). Similarly to previous reports, he highest 
rate of CNS was reported in the adult ICUs (32.0%) 
and Paediatric Departments (28.4%) due to the high 
usage of central venous catheters in adult critically ill 
patients and premature neonates (Wisplinghoff et al., 
2004; Pereira et al., 2013).
Contamination rate among positive blood cultures 
(24.7%) was comparable to that reported in previous 
studies (16.5–19.5%) (Kitaura et al., 2014; Chang et al., 
2015; Khatib et al., 2015). This finding may be explained by 
the low adherence to antiseptic procedures due to low 
nurse-to-patient ratio in Greek hospitals (Papadimitriou- 
Olivgeri et al., 2015). The probability of contamination 
and true bloodstream infection depends on the identity 
of the isolated pathogen, therefore, no blood culture 
positive for Gram-negative bacteria or fungi was judged 
to be contaminated in our Setting. (Kitaura et al., 2014; 
Chang et al., 2015; Khatib et al., 2015). On the contrary, 
among 72 Corynebacterium spp., 30 Micro coccus spp., 
27 Bacillus spp. and 25 Propionibacterium spp. iso-
lated from positive blood cultures, only five (6.9%), 
two (6.7%), two (7.4%) and three (12.0%) true BSIs 
were verified, respectively, results comparable to those 
previously reported (Urban, 2012; Kitaura et al., 2014; 
Chang et al., 2015). Despite the fact that CNS were 
the most commonly isolated pathogen from positive 
blood cultures (39.2%), they accounted for only 19.1% 
of BSIs. Since CNS are normal skin commensals, the 
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contamination rate of blood cultures was high (52.2%). 
Moreover, among CNS, S. epidermidis isolates were 
associated with a significantly lower contamination 
rate as compared to non-S. epidermidis (39.1% vs 
73.3%; P < 0.001), in accordance with other investiga-
tors. (Uyanik et al., 2014; Papadimitriou-Olivgeri et al., 
2015) Thus, it is imperative to distinguish true BSIs, 
since contamination may lead to unnecessary antibiotic 
consumption. (Papadimitriou-Olivgeri et al., 2015)
A low percentage of BSIs were catheter-related 
(18.0%), comparable to that reported from other inves-
tigators (8.2–24.0%), but lower to that from the point 
prevalence study in Europe (39.5%) (Wisplinghoff et al., 
2004; Rodriguez-Creixems et al., 2013; ECDC, 2013). 
Gram-positive bacteria were the most commonly iso-
lated pathogens (65.7%) from CR-BSIs, as previously 
shown, whereas, CNS predominated (Rodriguez- 
Creixems et al., 2013; Papadimitriou-Olivgeri et al., 
2015). In a study from Israel, Gram-negative bacteria 
accounted for 76.4% of CR-BSIs, whereas, the low per-
centage of Gram-positive bacteria was due to the low 
percentage of CNS CR-BSIs (0.8%), which in our setting 
accounted for 63.8% of cases (Braun et al., 2014). 
Another important finding of the present study was 
the high incidence of bacteremic brucellosis in South-
western Greece. While brucellosis remains a rare infec-
tion in Europe, high notification rates were reported 
from Mediterranean countries that were not officially 
brucellosis-free in animal populations (cattle, sheep 
or goats) (EFSA and ECDC, 2015). The highest rate 
of human brucellosis was reported from Greece which 
increased from 0.9 per 100 000  habitants in 2011 to 
1.4 in 2013, comparable to that found in the present 
study (EFSA and ECDC, 2015). Even though, no sig-
nificant variation in brucellosis trends was found in 
Europe during 2011–3, we shown a significant increase 
in B. melitensis bacteremia, which may be attributed to 
lack of animal vaccination and consumption of raw 
non-heat treated cheese that remains the main risk 
factor for brucellosis (EFSA and ECDC, 2015; Kara-
giannis et al., 2012). As previously shown, in addition to 
population health education, the complete and proper 
animal vaccination can lead to reduction of human bru-
cellosis (Jelastopulu et al., 2008).
Resistance among tested pathogens was high in 
the present study and coincided to the rates reported 
for Greece from the ECDC (ECDC, 2015). MRSA 
rates among S. aureus were 40.0%, a fact that may be 
attributed to the dissemination of the highly success-
ful ST80 clone not only in the community, but also 
in the hospital (Drougka et al., 2014; Papadimitriou-
Olivgeris et al., 2015). Methicillin-resistance among 
CNS was even higher, as previously shown, while VRE 
rates were lower (Papadimitriou-Olivgeri et al., 2015; 
Papadimitriou-Olivgeris et al., 2015; ECDC, 2015). 
The most important issue in our study was the pres-
ence of carbapenem-resistance among Gram-negative 
bacteria. The rates were higher among K. pneumoniae, 
which in their majority produced the carbapenemase 
KPC. This is in accordance with a previous Greek study 
from 31 hospitals (Koupetori et al., 2014). As compared 
to other Gram-negative nosocomial bacteria, Klebsiella 
spp. were associated with persistent BSI (2.2 positive 
blood culture bottles per BSI as compared to 1.9). 
In a previous study in our adult general ICU during 
2010–12, persistence of K. pneumoniae BSIs was due 
,to inappropriate empiric therapy, which may also 
explain the findings of the present study, since only 
67.9% of patients with KPC-producing K. pneumoniae 
BSIs received appropriate antibiotic therapy (Kang 
et al., 2013; Papadimitriou-Olivgeris et al., 2014a). 
Carbapenem-resistance rates among P. aeruginosa and 
Acinetobacter spp. were lower than that reported from 
ECDC (ECDC, 2015). Even though Gram-negative 
BSI incidence remained stable over time, a signifi-
cant increase was observed in carbapenem-resistant 
BSI incidence. This was propagated by the low nurse- 
to-patient ratio, the absence of isolation rooms (< 5%) 
and the high antibiotic consumption in Greek hospitals 
(rate 54.7%) (ECDC, 2013). 
Seasonality is an important issue for healthcare-
associated infections (Eber et al., 2011; Paul, 2012). 
In our study, total BSI incidence was higher during 
summer months due to higher incidence of Candida 
spp. and Gram-negative bacteria during these months, 
especially Klebsiella spp., Acinetobacter spp. and 
P. aeru ginosa. It was previously proven that Gram-
negative BSI incidence increases proportionately 
to temperature’s increase (Paul, 2012; Schwab et al., 
2014). Even though, this was shown for E. coli, we 
found no difference in seasonal distribution of E. coli 
(de Kraker et al., 2013; Schwab et al., 2014). This is the 
first study to demonstrate higher CNS BSIs incidence 
in winter months, which cannot be explained by tem-
perature-dependence of CNS. Seasonality was previ-
ously found among S. aureus infections, with higher 
incidence during summer months and autumn (Paul, 
2012; Schwab et al., 2014). No such association was 
found in the present study. 
Candidemia comprises an important cause of 
BSIs worldwide, associated with high mortality rates 
(Wisplinghoff et al., 2004; Falagas et al., 2010). In our 
study, BSIs due to Candida spp. accounted for 6.5% of 
all BSI, with a predominance of C. non-albicans species 
(61.1%). A great variability in distribution of different 
Candida spp., with C. albicans being the dominant spe-
cies in North and Central Europe and C. non-albicans 
species in South America, South Europe, and Asia has 
been reported in a systematic review (Falagas et al., 
2010). It is also shown that the percentage of C. non-
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albicans falls steadily during the last decade worldwide 
(Falagas et al., 2010). During an eleven-year period 
(1998–2008), candidemias accounted for 3.3% of BSIs 
in UGHP with C. albicans being the predominant spe-
cies (64.0%) (Spiliopoulou et al., 2010). This abrupt 
change in Candida spp. epidemiology in our Institution 
can be explained by the dissemination of KPC-produc-
ing K. pneumoniae BSIs. In a previous study among ICU 
patients we showed that KPC-producing K. pneumoniae 
BSIs predispose to candidemia and selection of C. non-
albicans species (Papadimitriou-Olivgeris et al., 2014b). 
Similarly, same results are shown in the present study, 
since previous episodes of KPC-producing K. pneumo-
niae was significantly higher among candidemia due 
to C. non-albicans species as compared to C. albicans. 
Candidemia showed seasonality in the present study, 
being significantly higher in summer months as com-
pared to winter ones, a finding that reinforces previ-
ously published results of a previous study, where hospi-
talization during summer months was an independent 
risk factor for Candida spp. isolation. (Papadimitriou-
Olivgeris et al., 2014b)
The present study has several limitations. No clinical 
data were included rendering the calculation of BSIs 
mortality or the role of appropriate treatment in survival 
impossible. Second, this is a single center study; how-
ever, it reflects not only the local epidemiology but also 
the national one (ECDC, 2013; Koupetori et al., 2014; 
Papadimitriou-Olivgeris et al., 2015). Despite the evalu-
ation of seasonality, no temperature data were included. 
In conclusion, BSIs remain an important cause of 
healthcare-associated infections. The increasing inci-
dence of BSIs was due to similar increase of Gram-
positive BSI incidence, even though Gram-negative 
bacteria were the predominant ones. CNS was the most 
commonly isolated pathogen from bacteremic patients 
and was more common during winter months, in con-
trast to summer occurrence of Gram-negative bacteria 
especially Klebsiella spp. Antibiotic resistance of both 
Gram-positive cocci and Gram-negative bacilli was 
high, contributing in their dissemination in the hospital 
environment. Candida epidemiology changed abruptly 
the last years, with C. non-albicans species being the 
predominant ones, probably due to the high incidence 
of KPC-producing K. pneumoniae since it is shown to 
be a prelude of C. non-albicans candidemia. In the con-
text of budgetary crisis, absence of isolation rooms, low 
nurse-to-patient ratio and high antibiotic consumption, 
even though intensive effort in infection control meas-
ures is made, they remain inefficacious.
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